









Markets
/
Stocks
/
nasdaq-sens
/

Senseonics Holdings Inc

SENS

0.455USD

+0.008+1.74%

Close 09/18, 16:00（ET）Quotes delayed by 15 min

370.88MMarket Cap

LossP/E TTM



Senseonics Holdings Inc

0.455

+0.008+1.74%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-18

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

121 / 207

Overall Ranking

308 / 4721

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 7 analysts

Buy

Current Rating

1.430

Target Price

+219.55%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 37.12% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 22.47M.

Fairly Valued

The company’s latest PE is -4.61, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 161.77M shares, increasing 15.79% quarter-over-quarter.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.18.

Financial Health

Currency: USD Updated: 2025-09-18

The company's current financial score is 5.55, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 6.65M, representing a year-over-year increase of 36.67%, while its net profit experienced a year-over-year increase of 28.52%.

Score

Industry at a Glance

Previous score

5.55

Change



Financials

7.73

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.09

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.77

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

3.08

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.09

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-18

The company’s current valuation score is 1.20, which is lower than the Healthcare Equipment & Supplies industry's average of 2.00. Its current P/E ratio is -4.53, which is -42.81% below the recent high of -2.59 and -12.07% above the recent low of -5.08.

Score

Industry at a Glance

Previous score

1.20

Change

1.6

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 121/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-18

The company’s current earnings forecast score is 7.14, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Senseonics Holdings Inc is 1.40, with a high of 2.00 and a low of 1.00.

Score

Industry at a Glance

Previous score

7.14

Change

Support & Resistance

No Data

Analyst Rating

Based on 7 analysts

Buy

Current Rating

1.430

Target Price

+219.55%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Senseonics Holdings Inc

SENS

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-18

The company’s current price momentum score is 6.31, which is lower than the Healthcare Equipment & Supplies industry's average of 6.45. Sideways: Currently, the stock price is trading between the resistance level at 0.50 and the support level at 0.41, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.31

Change

0.04

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

0.005

Neutral

RSI(14)

47.090

Neutral

STOCH(KDJ)(9,3,3)

44.851

Buy

ATR(14)

0.019

High Vlolatility

CCI(14)

21.029

Neutral

Williams %R

68.196

Sell

TRIX(12,20)

-0.279

Sell

StochRSI(14)

82.897

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

0.453

Buy

MA10

0.450

Buy

MA20

0.452

Buy

MA50

0.486

Sell

MA100

0.521

Sell

MA200

0.610

Sell

Institutional Confidence

Currency: USD Updated: 2025-09-18

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Energy Capital, L.L.C.

42.60M

+264.10%

First Light Asset Management, LLC

4.66M

-27.59%

The Vanguard Group, Inc.

Star Investors

25.69M

+15.93%

BlackRock Institutional Trust Company, N.A.

12.19M

+48.70%

Geode Capital Management, L.L.C.

6.87M

+7.30%

Goodnow (Timothy Todd)

8.64M

-0.91%

Masters Capital Management, L.L.C.

4.50M

-35.71%

Risk Assessment

Currency: USD Updated: 2025-09-18

The company’s current risk assessment score is 3.11, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.85. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.